Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COVID-19; COVID-19; This is a spontaneous report received from a consumer. A 35-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. During an inbound call for financial assistance, the patient wanted to know what she has to do to try to lower the cost of COVID-19 medicine, because she currently has COVID. The patient got COVID and got to take a break from work. The patient remembers when this stuff was free. The patient had nirmatrelvir/ritonavir (PAXLOVID) before for COVID. Per patient, it didn't feel like this time. The patient was sicker than she was last time. But the patient had a couple shots and boosters, but then she hadn't had it in a long time. The patient had been in the patient assistance program before. The patient inquired if she could go take that COVID shot.